Melanopsin for precise optogenetic activation of astrocyte-neuron networks

Glia. 2019 May;67(5):915-934. doi: 10.1002/glia.23580. Epub 2019 Jan 11.

Abstract

Optogenetics has been widely expanded to enhance or suppress neuronal activity and it has been recently applied to glial cells. Here, we have used a new approach based on selective expression of melanopsin, a G-protein-coupled photopigment, in astrocytes to trigger Ca2+ signaling. Using the genetically encoded Ca2+ indicator GCaMP6f and two-photon imaging, we show that melanopsin is both competent to stimulate robust IP3-dependent Ca2+ signals in astrocyte fine processes, and to evoke an ATP/Adenosine-dependent transient boost of hippocampal excitatory synaptic transmission. Additionally, under low-frequency light stimulation conditions, melanopsin-transfected astrocytes can trigger long-term synaptic changes. In vivo, melanopsin-astrocyte activation enhances episodic-like memory, suggesting melanopsin as an optical tool that could recapitulate the wide range of regulatory actions of astrocytes on neuronal networks in behaving animals. These results describe a novel approach using melanopsin as a precise trigger for astrocytes that mimics their endogenous G-protein signaling pathways, and present melanopsin as a valuable optical tool for neuron-glia studies.

Keywords: astrocytes; melanopsin; neuron-glia interactions; optogenetics; synaptic plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • Adenosine A2 Receptor Antagonists / pharmacology
  • Alanine / analogs & derivatives
  • Alanine / pharmacology
  • Animals
  • Astrocytes / metabolism*
  • Azo Compounds / pharmacology
  • Channelrhodopsins / genetics
  • Channelrhodopsins / metabolism
  • Chelating Agents / pharmacology
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glial Fibrillary Acidic Protein / genetics
  • Glial Fibrillary Acidic Protein / metabolism
  • Hippocampus / cytology
  • Inositol 1,4,5-Trisphosphate Receptors / genetics
  • Inositol 1,4,5-Trisphosphate Receptors / metabolism
  • Light
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Nerve Net / metabolism*
  • Neurons / metabolism*
  • Optogenetics / methods*
  • Pyridoxal Phosphate / analogs & derivatives
  • Pyridoxal Phosphate / pharmacology
  • Pyrimidines / pharmacology
  • Rod Opsins / genetics
  • Rod Opsins / metabolism*
  • Synaptic Potentials / physiology
  • Triazoles / pharmacology
  • Xanthenes / pharmacology

Substances

  • 2-amino-2-(4-carboxyphenyl)-3-(9H-xanthen-9-yl)propanoic acid
  • 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine
  • Adenosine A2 Receptor Antagonists
  • Azo Compounds
  • Channelrhodopsins
  • Chelating Agents
  • Excitatory Amino Acid Antagonists
  • Glial Fibrillary Acidic Protein
  • Inositol 1,4,5-Trisphosphate Receptors
  • Ip3r2 protein, mouse
  • MRS2159
  • Pyrimidines
  • Rod Opsins
  • Triazoles
  • Xanthenes
  • melanopsin
  • Egtazic Acid
  • Pyridoxal Phosphate
  • 2-Amino-5-phosphonovalerate
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Alanine